New Delhi, Sept. 26 -- Sun Pharmaceutical Industries, Lupin, and other Indian pharma stocks will be in focus on Friday after the US President Donald Trump announced a fresh 100% tariffs on branded or patented pharmaceuticals starting October 1, unless a company is building a manufacturing plant in America.

Trump posted on his Truth Social that there would be no levies on pharmaceutical imports if companies have broken ground on a US manufacturing plant, or if such a plant is under construction.

"Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. 'IS BUILDING' will be defined as, 'breaking ground...